ReviewDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2019
[Duodenum-preserving pancreatic head resection : A local parenchyma-sparing treatment of benign and premalignant tumors of the pancreatic head].
Review in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 8 citations in OpenAlex.
- Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis.Journal of clinical medicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn contrast to the Kausch-Whipple procedure (pancreatoduodenectomy) duodenum-preserving pancreatic head resection (DPPHR) is associated with tissue sparing and maintenance of the pancreatic metabolic functions.
aimAccording to the results of controlled clinical trials the DPPHR procedure for benign pancreatic neoplasms is associated with low surgery-related complications and maintenance of glucose metabolism and exocrine pancreatic functions. This overview summarizes the clinical results of the use of DPPHR for chronic pancreatitis and benign tumors of the pancreatic head and the status of the clinical evidence of the results. MATERIAL AND
methodsThe literature review included the results of all prospective, prospective-controlled and randomized clinical trials and meta-analyses, which analyzed and compared pancreatoduodenectomy and DPPHR for chronic pancreatitis and benign neoplasms of the pancreas.
resultsCompared to pancreatoduodenectomy, DPPHR exhibits significantly shorter times for surgery, shorter intensive care unit and hospital stays, lower intraoperative blood loss, lower frequency of disorders of gastric emptying and preservation of pancreatic functions. Chronic pancreatitis pancreatic fistula rates, hospital mortality and quality of life were equally low after both operations. The use of DPPHR for benign, premalignant neoplasms in adults and children and for periampullary low-risk malignancies has the advantage of a long-lasting preservation of endocrine and exocrine pancreatic functions and gastrointestinal motility.
conclusionThe use of DPPHR for benign, premalignant, cystic and neuroendocrine neoplasms of the pancreatic head is associated with major advantages in the early postoperative course and preservation of gastrointestinal and pancreatic functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.